Table 2.

(a) Logistic analyses modeling responses of “likely” or “very likely” to participate in clinical trials; (b) logistic analyses modeling responses of “likely” or “very likely” to participate in observational research.

(a)
TypeClinical drug trialClinical drug trial with biospecimen collection researchClinical drug trial research including colonoscopy
% likely or very likely516438
(a)
TypeClinical drug trialClinical drug trial with biospecimen collection researchClinical drug trial research including colonoscopy
% likely or very likely516438
PredictorsOR (95% CI)POR (95% CI)POR (95% CI)P
Age1.01 (0.99-1.02).301.01 (0.99-1.03).311.00 (0.98-1.02).92
IBD
Other0.95 (0.59-1.55).840.83 (0.49-1.4).480.85 (0.52-1.40).52
UC1.00 (0.75-1.34).990.78 (0.57-1.06).111.21 (0.90-1.63).21
CDrefrefref
Education1.00 (0.89-1.14).951.04 (0.91-1.18).611.06 (0.94-1.21).34
Income0.98 (0.91-1.07).711.09 (0.99-1.19).0680.99 (0.91-1.08).88
Awareness
Veryrefrefref
Somewhat0.72 (0.51-1.03).0720.77 (0.52-1.13).190.69 (0.49-0.98).037
None0.51 (0.33-0.77).00150.46 (0.3-0.72).00070.54 (0.35-0.82).0044
Previous trials (Y vs N)1.65 (1.21-2.26).00181.58 (1.12-2.22).00971.32 (0.97-1.8).081
Reason
Access to experts0.88 (0.43-1.81).720.62 (0.3-1.3).20660.47 (0.2-1.09).077
Doctor recommendation0.51 (0.24-1.06).0690.34 (0.16-0.7).00370.59 (0.27-1.28).18
Improve my life1.21 (0.86-1.70).281 (0.7-1.45).991.01 (0.72-1.43).96
Newest therapies1.14 (0.6-2.17).680.57 (0.29-1.1).09091.11 (0.59-2.1).75
New-to-me therapies1.11 (0.53-2.33).791.11 (0.49-2.51).811.43 (0.69-2.96).33
More tests1.00 (0.42-2.41)1.001.72 (0.6-4.96).311.53 (0.63-3.71).35
Other0.39 (0.20-0.76).00560.51 (0.26-0.97).0420.65 (0.33-1.27).21
Increase knowledgerefrefref
Male1.22 (0.91-1.62).180.81 (0.60-1.10).181.28 (0.96-1.71).10
Receiving results
Eventually0.86 (0.62-1.19).370.68 (0.48-0.96).0290.69 (0.5-0.96).027
within 6 months0.67 (0.4-1.15).150.47 (0.27-0.82).00770.74 (0.43-1.28).27
within 1 year0.8 (0.53-1.22).310.61 (0.39-0.94).0260.6 (0.39-0.93).022
don’t carerefrefref
Comorbidities (Y vs N)0.99 (0.73-1.34).950.86 (0.62-1.19).370.99 (0.73-1.35).97
Depression/anxiety (Y vs N)0.92 (0.67-1.27).611.28 (0.9-1.81).171.07 (0.77-1.48).69
Employment
Other vs full-time0.81 (0.54-1.22).321.13 (0.73-1.75).581.46 (0.97-2.19).072
Retired vs full-time0.9 (0.58-1.38).631.07 (0.68-1.69).771.26 (0.81-1.94).30
PredictorsOR (95% CI)POR (95% CI)POR (95% CI)P
Age1.01 (0.99-1.02).301.01 (0.99-1.03).311.00 (0.98-1.02).92
IBD
Other0.95 (0.59-1.55).840.83 (0.49-1.4).480.85 (0.52-1.40).52
UC1.00 (0.75-1.34).990.78 (0.57-1.06).111.21 (0.90-1.63).21
CDrefrefref
Education1.00 (0.89-1.14).951.04 (0.91-1.18).611.06 (0.94-1.21).34
Income0.98 (0.91-1.07).711.09 (0.99-1.19).0680.99 (0.91-1.08).88
Awareness
Veryrefrefref
Somewhat0.72 (0.51-1.03).0720.77 (0.52-1.13).190.69 (0.49-0.98).037
None0.51 (0.33-0.77).00150.46 (0.3-0.72).00070.54 (0.35-0.82).0044
Previous trials (Y vs N)1.65 (1.21-2.26).00181.58 (1.12-2.22).00971.32 (0.97-1.8).081
Reason
Access to experts0.88 (0.43-1.81).720.62 (0.3-1.3).20660.47 (0.2-1.09).077
Doctor recommendation0.51 (0.24-1.06).0690.34 (0.16-0.7).00370.59 (0.27-1.28).18
Improve my life1.21 (0.86-1.70).281 (0.7-1.45).991.01 (0.72-1.43).96
Newest therapies1.14 (0.6-2.17).680.57 (0.29-1.1).09091.11 (0.59-2.1).75
New-to-me therapies1.11 (0.53-2.33).791.11 (0.49-2.51).811.43 (0.69-2.96).33
More tests1.00 (0.42-2.41)1.001.72 (0.6-4.96).311.53 (0.63-3.71).35
Other0.39 (0.20-0.76).00560.51 (0.26-0.97).0420.65 (0.33-1.27).21
Increase knowledgerefrefref
Male1.22 (0.91-1.62).180.81 (0.60-1.10).181.28 (0.96-1.71).10
Receiving results
Eventually0.86 (0.62-1.19).370.68 (0.48-0.96).0290.69 (0.5-0.96).027
within 6 months0.67 (0.4-1.15).150.47 (0.27-0.82).00770.74 (0.43-1.28).27
within 1 year0.8 (0.53-1.22).310.61 (0.39-0.94).0260.6 (0.39-0.93).022
don’t carerefrefref
Comorbidities (Y vs N)0.99 (0.73-1.34).950.86 (0.62-1.19).370.99 (0.73-1.35).97
Depression/anxiety (Y vs N)0.92 (0.67-1.27).611.28 (0.9-1.81).171.07 (0.77-1.48).69
Employment
Other vs full-time0.81 (0.54-1.22).321.13 (0.73-1.75).581.46 (0.97-2.19).072
Retired vs full-time0.9 (0.58-1.38).631.07 (0.68-1.69).771.26 (0.81-1.94).30
(b)
TypeResearch using health recordsResearch using records & specimens
% likely or very likely8571
(b)
TypeResearch using health recordsResearch using records & specimens
% likely or very likely8571
PredictorsOR (95% CI)POR (95% CI)P
Age1.00 (0.97-1.02).681.00 (0.98-1.02).88
IBD
Other1.11 (0.50-2.46).800.89 (0.51-1.54)
UC0.81 (0.52-1.27).370.84 (0.61-1.17).30
CDrefref
Education1.05 (0.87-1.27).591.01 (0.88-1.16).87
Income1.02 (0.90-1.16).741.02 (0.93-1.12).67
Awareness
VeryRefref
Somewhat0.47 (0.25-0.87).0170.90 (0.60-1.35).61
None0.31 (0.16-0.63).00110.62 (0.39-0.98).041
Previous trials (Y vs N)0.60 (0.37-0.95).0301.2 (0.84-1.71).33
Reason
Access to experts0.53 (0.22-1.29).160.98 (0.45-2.12).96
Doctor recommendation0.98 (0.35-2.76).960.49 (0.24-1).051
Improve my life0.98 (0.57-1.67).941.13 (0.76-1.66).55
Newest therapies0.76 (0.30-1.89).551.01 (0.49-2.07).98
New-to-me therapies0.82 (0.26-2.51).721.10 (0.47-2.56).83
More tests1.16 (0.25-5.34).851.01 (0.38-2.74).98
Other0.54 (0.23-1.30).170.80 (0.40-1.60).53
Increase knowledgerefref
Male0.75 (0.49-1.16).200.84 (0.61-1.16).29
Receiving results
eventually0.70 (0.41-1.18).180.73 (0.50-1.06).094
within 6 months0.28 (0.15-0.54).00020.39 (0.23-0.68).0009
within 1 year0.60 (0.32-1.13).110.57 (0.36-0.90).015
don’t carerefref
Comorbidities (Y vs N)0.93 (0.59-1.47).750.96 (0.68-1.34).79
Depression/anxiety (Y vs N)0.70 (0.44-1.12).140.83 (0.58-1.18).30
Employment
Other vs full-time1.62 (0.81-3.26).181.44 (0.90-2.30).13
Retired vs full-time1.08 (0.56-2.1).811.17 (0.72-1.88).53
PredictorsOR (95% CI)POR (95% CI)P
Age1.00 (0.97-1.02).681.00 (0.98-1.02).88
IBD
Other1.11 (0.50-2.46).800.89 (0.51-1.54)
UC0.81 (0.52-1.27).370.84 (0.61-1.17).30
CDrefref
Education1.05 (0.87-1.27).591.01 (0.88-1.16).87
Income1.02 (0.90-1.16).741.02 (0.93-1.12).67
Awareness
VeryRefref
Somewhat0.47 (0.25-0.87).0170.90 (0.60-1.35).61
None0.31 (0.16-0.63).00110.62 (0.39-0.98).041
Previous trials (Y vs N)0.60 (0.37-0.95).0301.2 (0.84-1.71).33
Reason
Access to experts0.53 (0.22-1.29).160.98 (0.45-2.12).96
Doctor recommendation0.98 (0.35-2.76).960.49 (0.24-1).051
Improve my life0.98 (0.57-1.67).941.13 (0.76-1.66).55
Newest therapies0.76 (0.30-1.89).551.01 (0.49-2.07).98
New-to-me therapies0.82 (0.26-2.51).721.10 (0.47-2.56).83
More tests1.16 (0.25-5.34).851.01 (0.38-2.74).98
Other0.54 (0.23-1.30).170.80 (0.40-1.60).53
Increase knowledgerefref
Male0.75 (0.49-1.16).200.84 (0.61-1.16).29
Receiving results
eventually0.70 (0.41-1.18).180.73 (0.50-1.06).094
within 6 months0.28 (0.15-0.54).00020.39 (0.23-0.68).0009
within 1 year0.60 (0.32-1.13).110.57 (0.36-0.90).015
don’t carerefref
Comorbidities (Y vs N)0.93 (0.59-1.47).750.96 (0.68-1.34).79
Depression/anxiety (Y vs N)0.70 (0.44-1.12).140.83 (0.58-1.18).30
Employment
Other vs full-time1.62 (0.81-3.26).181.44 (0.90-2.30).13
Retired vs full-time1.08 (0.56-2.1).811.17 (0.72-1.88).53
Table 2.

(a) Logistic analyses modeling responses of “likely” or “very likely” to participate in clinical trials; (b) logistic analyses modeling responses of “likely” or “very likely” to participate in observational research.

(a)
TypeClinical drug trialClinical drug trial with biospecimen collection researchClinical drug trial research including colonoscopy
% likely or very likely516438
(a)
TypeClinical drug trialClinical drug trial with biospecimen collection researchClinical drug trial research including colonoscopy
% likely or very likely516438
PredictorsOR (95% CI)POR (95% CI)POR (95% CI)P
Age1.01 (0.99-1.02).301.01 (0.99-1.03).311.00 (0.98-1.02).92
IBD
Other0.95 (0.59-1.55).840.83 (0.49-1.4).480.85 (0.52-1.40).52
UC1.00 (0.75-1.34).990.78 (0.57-1.06).111.21 (0.90-1.63).21
CDrefrefref
Education1.00 (0.89-1.14).951.04 (0.91-1.18).611.06 (0.94-1.21).34
Income0.98 (0.91-1.07).711.09 (0.99-1.19).0680.99 (0.91-1.08).88
Awareness
Veryrefrefref
Somewhat0.72 (0.51-1.03).0720.77 (0.52-1.13).190.69 (0.49-0.98).037
None0.51 (0.33-0.77).00150.46 (0.3-0.72).00070.54 (0.35-0.82).0044
Previous trials (Y vs N)1.65 (1.21-2.26).00181.58 (1.12-2.22).00971.32 (0.97-1.8).081
Reason
Access to experts0.88 (0.43-1.81).720.62 (0.3-1.3).20660.47 (0.2-1.09).077
Doctor recommendation0.51 (0.24-1.06).0690.34 (0.16-0.7).00370.59 (0.27-1.28).18
Improve my life1.21 (0.86-1.70).281 (0.7-1.45).991.01 (0.72-1.43).96
Newest therapies1.14 (0.6-2.17).680.57 (0.29-1.1).09091.11 (0.59-2.1).75
New-to-me therapies1.11 (0.53-2.33).791.11 (0.49-2.51).811.43 (0.69-2.96).33
More tests1.00 (0.42-2.41)1.001.72 (0.6-4.96).311.53 (0.63-3.71).35
Other0.39 (0.20-0.76).00560.51 (0.26-0.97).0420.65 (0.33-1.27).21
Increase knowledgerefrefref
Male1.22 (0.91-1.62).180.81 (0.60-1.10).181.28 (0.96-1.71).10
Receiving results
Eventually0.86 (0.62-1.19).370.68 (0.48-0.96).0290.69 (0.5-0.96).027
within 6 months0.67 (0.4-1.15).150.47 (0.27-0.82).00770.74 (0.43-1.28).27
within 1 year0.8 (0.53-1.22).310.61 (0.39-0.94).0260.6 (0.39-0.93).022
don’t carerefrefref
Comorbidities (Y vs N)0.99 (0.73-1.34).950.86 (0.62-1.19).370.99 (0.73-1.35).97
Depression/anxiety (Y vs N)0.92 (0.67-1.27).611.28 (0.9-1.81).171.07 (0.77-1.48).69
Employment
Other vs full-time0.81 (0.54-1.22).321.13 (0.73-1.75).581.46 (0.97-2.19).072
Retired vs full-time0.9 (0.58-1.38).631.07 (0.68-1.69).771.26 (0.81-1.94).30
PredictorsOR (95% CI)POR (95% CI)POR (95% CI)P
Age1.01 (0.99-1.02).301.01 (0.99-1.03).311.00 (0.98-1.02).92
IBD
Other0.95 (0.59-1.55).840.83 (0.49-1.4).480.85 (0.52-1.40).52
UC1.00 (0.75-1.34).990.78 (0.57-1.06).111.21 (0.90-1.63).21
CDrefrefref
Education1.00 (0.89-1.14).951.04 (0.91-1.18).611.06 (0.94-1.21).34
Income0.98 (0.91-1.07).711.09 (0.99-1.19).0680.99 (0.91-1.08).88
Awareness
Veryrefrefref
Somewhat0.72 (0.51-1.03).0720.77 (0.52-1.13).190.69 (0.49-0.98).037
None0.51 (0.33-0.77).00150.46 (0.3-0.72).00070.54 (0.35-0.82).0044
Previous trials (Y vs N)1.65 (1.21-2.26).00181.58 (1.12-2.22).00971.32 (0.97-1.8).081
Reason
Access to experts0.88 (0.43-1.81).720.62 (0.3-1.3).20660.47 (0.2-1.09).077
Doctor recommendation0.51 (0.24-1.06).0690.34 (0.16-0.7).00370.59 (0.27-1.28).18
Improve my life1.21 (0.86-1.70).281 (0.7-1.45).991.01 (0.72-1.43).96
Newest therapies1.14 (0.6-2.17).680.57 (0.29-1.1).09091.11 (0.59-2.1).75
New-to-me therapies1.11 (0.53-2.33).791.11 (0.49-2.51).811.43 (0.69-2.96).33
More tests1.00 (0.42-2.41)1.001.72 (0.6-4.96).311.53 (0.63-3.71).35
Other0.39 (0.20-0.76).00560.51 (0.26-0.97).0420.65 (0.33-1.27).21
Increase knowledgerefrefref
Male1.22 (0.91-1.62).180.81 (0.60-1.10).181.28 (0.96-1.71).10
Receiving results
Eventually0.86 (0.62-1.19).370.68 (0.48-0.96).0290.69 (0.5-0.96).027
within 6 months0.67 (0.4-1.15).150.47 (0.27-0.82).00770.74 (0.43-1.28).27
within 1 year0.8 (0.53-1.22).310.61 (0.39-0.94).0260.6 (0.39-0.93).022
don’t carerefrefref
Comorbidities (Y vs N)0.99 (0.73-1.34).950.86 (0.62-1.19).370.99 (0.73-1.35).97
Depression/anxiety (Y vs N)0.92 (0.67-1.27).611.28 (0.9-1.81).171.07 (0.77-1.48).69
Employment
Other vs full-time0.81 (0.54-1.22).321.13 (0.73-1.75).581.46 (0.97-2.19).072
Retired vs full-time0.9 (0.58-1.38).631.07 (0.68-1.69).771.26 (0.81-1.94).30
(b)
TypeResearch using health recordsResearch using records & specimens
% likely or very likely8571
(b)
TypeResearch using health recordsResearch using records & specimens
% likely or very likely8571
PredictorsOR (95% CI)POR (95% CI)P
Age1.00 (0.97-1.02).681.00 (0.98-1.02).88
IBD
Other1.11 (0.50-2.46).800.89 (0.51-1.54)
UC0.81 (0.52-1.27).370.84 (0.61-1.17).30
CDrefref
Education1.05 (0.87-1.27).591.01 (0.88-1.16).87
Income1.02 (0.90-1.16).741.02 (0.93-1.12).67
Awareness
VeryRefref
Somewhat0.47 (0.25-0.87).0170.90 (0.60-1.35).61
None0.31 (0.16-0.63).00110.62 (0.39-0.98).041
Previous trials (Y vs N)0.60 (0.37-0.95).0301.2 (0.84-1.71).33
Reason
Access to experts0.53 (0.22-1.29).160.98 (0.45-2.12).96
Doctor recommendation0.98 (0.35-2.76).960.49 (0.24-1).051
Improve my life0.98 (0.57-1.67).941.13 (0.76-1.66).55
Newest therapies0.76 (0.30-1.89).551.01 (0.49-2.07).98
New-to-me therapies0.82 (0.26-2.51).721.10 (0.47-2.56).83
More tests1.16 (0.25-5.34).851.01 (0.38-2.74).98
Other0.54 (0.23-1.30).170.80 (0.40-1.60).53
Increase knowledgerefref
Male0.75 (0.49-1.16).200.84 (0.61-1.16).29
Receiving results
eventually0.70 (0.41-1.18).180.73 (0.50-1.06).094
within 6 months0.28 (0.15-0.54).00020.39 (0.23-0.68).0009
within 1 year0.60 (0.32-1.13).110.57 (0.36-0.90).015
don’t carerefref
Comorbidities (Y vs N)0.93 (0.59-1.47).750.96 (0.68-1.34).79
Depression/anxiety (Y vs N)0.70 (0.44-1.12).140.83 (0.58-1.18).30
Employment
Other vs full-time1.62 (0.81-3.26).181.44 (0.90-2.30).13
Retired vs full-time1.08 (0.56-2.1).811.17 (0.72-1.88).53
PredictorsOR (95% CI)POR (95% CI)P
Age1.00 (0.97-1.02).681.00 (0.98-1.02).88
IBD
Other1.11 (0.50-2.46).800.89 (0.51-1.54)
UC0.81 (0.52-1.27).370.84 (0.61-1.17).30
CDrefref
Education1.05 (0.87-1.27).591.01 (0.88-1.16).87
Income1.02 (0.90-1.16).741.02 (0.93-1.12).67
Awareness
VeryRefref
Somewhat0.47 (0.25-0.87).0170.90 (0.60-1.35).61
None0.31 (0.16-0.63).00110.62 (0.39-0.98).041
Previous trials (Y vs N)0.60 (0.37-0.95).0301.2 (0.84-1.71).33
Reason
Access to experts0.53 (0.22-1.29).160.98 (0.45-2.12).96
Doctor recommendation0.98 (0.35-2.76).960.49 (0.24-1).051
Improve my life0.98 (0.57-1.67).941.13 (0.76-1.66).55
Newest therapies0.76 (0.30-1.89).551.01 (0.49-2.07).98
New-to-me therapies0.82 (0.26-2.51).721.10 (0.47-2.56).83
More tests1.16 (0.25-5.34).851.01 (0.38-2.74).98
Other0.54 (0.23-1.30).170.80 (0.40-1.60).53
Increase knowledgerefref
Male0.75 (0.49-1.16).200.84 (0.61-1.16).29
Receiving results
eventually0.70 (0.41-1.18).180.73 (0.50-1.06).094
within 6 months0.28 (0.15-0.54).00020.39 (0.23-0.68).0009
within 1 year0.60 (0.32-1.13).110.57 (0.36-0.90).015
don’t carerefref
Comorbidities (Y vs N)0.93 (0.59-1.47).750.96 (0.68-1.34).79
Depression/anxiety (Y vs N)0.70 (0.44-1.12).140.83 (0.58-1.18).30
Employment
Other vs full-time1.62 (0.81-3.26).181.44 (0.90-2.30).13
Retired vs full-time1.08 (0.56-2.1).811.17 (0.72-1.88).53
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close